ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Myriad Pharmaceuticals


Include trials that are no longer recruiting patients.

1 study was found.
1.No longer recruitingR-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act